Clinical applications of cortisol measurements in hair.
Cortisol measurements in blood, saliva and urine are frequently used to examine the hypothalamus-pituitary-adrenal (HPA) axis in clinical practice and in research. However, cortisol levels are subject to variations due to acute stress, the diurnal rhythm and pulsatile secretion. Cortisol measurements in body fluids are not always a reflection of long-term cortisol exposure. The analysis of cortisol in scalp hair is a relatively novel method to measure cumulative cortisol exposure over months up to years. Over the past years, hair cortisol concentrations (HCC) have been examined in association with a large number of somatic and mental health conditions. HCC can be used to evaluate disturbances of the HPA axis, including Cushing's syndrome, and to evaluate hydrocortisone treatment. Using HCC, retrospective timelines of cortisol exposure can be created which can be of value in diagnosing cyclic hypercortisolism. HCC have also been shown to increase with psychological stressors, including major life events, as well as physical stressors, such as endurance exercise and shift work. Initial studies show that HCC may be increased in depression, but decreased in general anxiety disorder. In posttraumatic stress disorder, changes in HCC seem to be dependent on the type of traumatic experience and the time since traumatization. Increased hair cortisol is consistently linked to obesity, metabolic syndrome and cardiovascular disease. Potentially, HCC could form a future marker for cardiovascular risk stratification, as well as serve as a treatment target.
Division of EndocrinologyDepartment of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands.
Vincent L
VL
Wester
Division of EndocrinologyDepartment of Internal Medicine, Erasmus MC, University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands e.vanrossum@erasmusmc.nl.
Elisabeth F C
EF
van Rossum
D000309:Adrenal Insufficiency / Q000188:drug therapy; D001008:Anxiety Disorders / Q000378:metabolism*; D015415:Biomarkers / Q000032:analysis / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000378:metabolism*; D002853:Chromatography, Liquid; D002940:Circadian Rhythm; D003480:Cushing Syndrome / Q000175:diagnosis* / Q000378:metabolism; D003866:Depressive Disorder / Q000378:metabolism*; D004797:Enzyme-Linked Immunosorbent Assay; D006197:Hair / Q000737:chemistry*; D020249:Hormone Replacement Therapy; D006801:Humans; D006854:Hydrocortisone / Q000032:analysis* / Q000378:metabolism / Q000627:therapeutic use; D007030:Hypothalamo-Hypophyseal System; D010913:Pituitary-Adrenal System; D013313:Stress Disorders, Post-Traumatic / Q000378:metabolism*; D053719:Tandem Mass Spectrometry
D015415:Biomarkers; D006854:Hydrocortisone